Tigecycline (Tygacil) has received an updated warning label from the Food and Drug Administration. The new label states that alternatives to Tygacil should be considered in treating serious infections due to Tygacil’s increased risk of mortaility in comparison with other antibiotics in treating infections.
According to an FDA safety alert, “alternatives to Tygacil should be considered in patients with severe infections.”
Click on the links for more information.
https://www.nexreg.com/wp-content/uploads/2023/01/USA-Icon.png 60 60 Nexreg https://www.nexreg.com/wp-content/uploads/2023/04/2023-NexregLogo-Transparent-SM-300x92.png Nexreg2010-09-13 12:35:202023-06-19 11:07:10Sept 13 - US: Tygacil Gets Updated Warning Label from FDA